ADVANZ PHARMA is committed to improving patients’ lives by enhancing the critical medicines they depend on.
Our goal is clear - to become the ‘go to partner’ when commercialising complex medicines in European hospitals.
Our focus on complex medicines means building a portfolio of hospital specific products and enhanced commercial and medical capabilities, in key therapeutic areas such as anti-infectives and endocrinology that bring innovation to improve patient access and health outcomes while our established products business with its portfolio of more than 180 molecules provides essential medicines globally to the patients that need them.
We do this through two distinct business divisions:
An expanding European Strategic Growth Business
Focusing on developing and commercialising complex medicines in the European hospitals market, our niche hospital portfolio across key therapy areas including Anti-Infectives, Endocrinology and Critical Care is supported by our in-house advanced commercial capability and in-depth relationships with healthcare professionals across Europe.
Leading, global Established Products Business
Diversified portfolio of established medicines with decades of prescription history and proven performance together with a global distribution network and 180+ molecules in key therapy areas such as pain management, ophthalmology, urology, central nervous system disorders and intensive care medicines, positioning us as a partner of choice for mature brands and niche differentiated generics.
Primed for scalability
Both divisions are underpinned by our virtual and lean operating model. Through our leading operations centre of excellence in Mumbai and across our global office locations, we provide medical, regulatory, quality and supply-chain capabilities supporting almost 100 countries.
It means we are able to acquire and integrate new products and companies quickly and efficiently and are always on the lookout for products that fit our strategic focus so that we can continue to expand and provide clear value to patients and healthcare providers.
Our supply chain – delivering on our purpose
It goes without saying that the Covid-19 pandemic brought immense pressure to our industry. Here at ADVANZ PHARMA, we have not wavered on our commitment to deliver essential medicines to those who need them. ADVANZ PHARMA has invested heavily in improving supply continuity, keeping above industry-average inventory levelsand having dual sourced supply in critical products which has been crucial during the pandemic.
Many of our medicines are used in intensive care units around the world, whilst others treat chronic conditions that don’t go away simply because the world’s attention is elsewhere – so ensuring continued supply and access is always our primary aim.